University of California

San Diego, California 92161

5 studies enrolling now · 39 studies all time

What they study most

Acne Vulgaris, Alpers Disease, Alpers Syndrome, Alpha-1 Antitrypsin Deficiency, Breast Cancer, Chronic Hepatitis C, Cystic Fibrosis, Diabetes, Diastolic Heart Failure, Drug Resistant Epilepsy, Duchenne Muscular Dystrophy, EGFR-mutated NSCLC (Disorder)

Studies at this site

• Multimodal Profiling of Response to Pediatric Comprehensive Behavioral Intervention for Tics — Recruiting now
• A Study of SGT-003 Gene Therapy in Duchenne Muscular Dystrophy (INSPIRE DUCHENNE) — Recruiting now
• Campath/Fludarabine/Melphalan Transplant Conditioning for Non-Malignant Diseases — Recruiting now
• Effect of Anti-inflammatory Diet in Osteoarthritis — Recruiting now
• PALbociclib CoLlaborative Adjuvant Study — Running, not enrolling
• Alpha-1 Antitrypsin Deficiency Adult Liver Study — Running, not enrolling
• A Study to Evaluate Efficacy and Safety of Vatiquinone for Treating Mitochondrial Disease in Participants With Refractory Epilepsy — Stopped early
• Evaluation of the Personal KinetiGraph™ (PKG™) to Improve Insight Into Parkinson's Disease Status — Running, not enrolling
• Mycobacteriophage Treatment of Non-tuberculosis Mycobacteria — Enrolling by invitation
• Acoustic Enhancer Research on Laser Lithotripsy (AEROLITH) — Completed
• A Study of Pridopidine (ACR16) for the Treatment of Participants With Huntington's Disease — Completed
• BEACH Trial: Bovine Early Access, Compatibility and Hemostasis Trial — Stopped early
• MP0250 DARPin® Protein Plus Osimertinib in Patients With EGFR-mutated NSCLC — Stopped early
• A Study of the Effectiveness of Sitaxsentan Sodium in Patients With Diastolic Heart Failure — Completed
• Evaluation of the Efficacy, Safety, and Tolerability of Sarizotan in Rett Syndrome With Respiratory Symptoms — Stopped early
• Open-Label Extension Trial to Characterize the Long-term Safety and Tolerability of Elamipretide in Subjects With Genetically Confirmed Primary Mitochondrial Myopathy (PMM) — Stopped early
• Treatment for Acute Graft-Versus-Host Disease (BMT CTN 0302) — Completed
• Elafibranor, PK and Safety in Children and Adolescents 8 to 17 Years of Age With Non Alcoholic Steatohepatitis (NASH) — Stopped early
• Clinical Study to Test the Efficacy and Safety of Adapalene, 0.1% — Completed
• Safety, Tolerability, Efficacy of MTP-131 for Treatment of Mitochondrial Disease in Subjects From the MMPOWER Study — Completed
• An Evaluation of the Safety and Efficacy of the dTMS Treatment for OCD — Completed
• Insulin Resistance Intervention After Stroke Trial — Completed
• Safety, Tolerability, and Efficacy of MTP-131 for the Treatment of Mitochondrial Myopathy — Completed
• Study of Netarsudil Ophthalmic Solution in Japanese/Japanese-American Subjects With Open-angle Glaucoma or Ocular Hypertension — Completed
• Dabigatran Etexilate for Secondary Stroke Prevention in Patients With Embolic Stroke of Undetermined Source (RE-SPECT ESUS) — Completed
• A Phase 3, Pivotal Trial of VB-111 Plus Bevacizumab vs. Bevacizumab in Patients With Recurrent Glioblastoma (GLOBE) — Completed
• Haptoglobin and Iron in Parkinson's Disease — Completed
• Human Heterologous Liver Cells for Infusion in Children With Urea Cycle Disorders — Stopped early
• Minocycline for the Treatment of Decreased Mental Function in HIV-Infected Adults — Stopped early
• Open-Label Study of Sofusbuvir+Ribavirin With or Without Peginterferon Alfa-2a in Subjects With Chronic HCV Infection Who Participated in Prior Gilead HCV Studies — Completed
• 24-hour Efficacy of AR-12286 — Completed
• TOMUS-Trial Of Mid-Urethral Slings — Completed
• Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children — Completed
• Value of Urodynamic Evaluation — Completed
• Behavior Enhances Drug Reduction of Incontinence (BE-DRI) — Completed
• Mixed Incontinence: Medical Or Surgical Approach? — Stopped early
• Comparison of Surgical Procedures to Reduce Urinary Stress Incontinence — Completed
• Switch to Atazanavir and Brachial Artery Reactivity (SABAR) Study — Completed
• A Safety Tolerance and Experimental Hyperalgesia Study of Oral NGX426 in Healthy Male Voluneteers — Completed